[Advantages and disadvantages of mucilaginous medication].

Guy M. Goodwin, Wolfgang Fleischhacker, Celso Arango, Pierre Baumann, Michael Davidson, Marc D. Binder, Peter Falkai, Shitij Kapur, Stefan Leucht, Rasmus Wentzer Licht, Dieter Naber, Veronica O’Keane, George I. Papakostas, Eduard Vieta, Joseph Zohar

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

Year: 1963
Published: —
Language: en

Article Details

Volume: 85
Link Of The Paper: https://pubmed.ncbi.nlm.nih.gov/13945171

Timeline

Created:June 19, 2026

Article2015

Advantages and disadvantages of unstructured cardiovascular risk factor screening for follow-up in primary care

Anna W. de Boer, Renée de Mutsert, Martin den Heijer, Frits R. Rosendaal, J. Wouter Jukema, Jeanet W. Blom, Mattijs E. Numans

European Journal of Preventive Cardiology

Article2024

Discontinuation of psychotropic medication: a synthesis of evidence across medication classes

Christiaan H. Vinkers, Ralph Kupka, Brenda W.J.H. Penninx, Henricus G. Ruhé, J M van Gaalen, Paul Cornelis Franciscus Van Haaren, Arnt Schellekens, Sameer Jauhar, Josep Antoni Ramos‐Quiroga, Eduard Vieta, Jari Tiihonen, Stijn E. Veldman, Wim Veling, Roeland Vis, Laura E De Wit, Jurjen J. Luykx

Article1951

[Aspects of pelvic medication].

Massimo Filippi

Article1989

The Advantages and Pitfalls of Electrochemical Impedance Spectroscopy

Digby D Macdonald